International Rhabdomyosarcoma Study Group(English)
- its Pathology Center reviews 75% of rhabdomyosarcoma cases in the United States. The ICR classification offers new morphologic concepts to the practicing pathologist, clearly defining the emerging histopathologic categories. Cardinal histopathologic features of the ICR combined with results of studies of fusion genes seen with t(1;13) and t(2;13) will help delineate therapeutic subgroups
- IRS, RMS
- Histochemistry, Oncology, Pediatrics, Pathology
- https://doi.org…1572-018-0051-2
- https://doi.org…7/s100249900076